Current Drug Treatment Strategies for Atrial Fibrillation and TASK-1 Inhibition as an Emerging Novel Therapy Option

• Główni autorzy: Manuel Kraft (Autor), Antonius Büscher (Autor), Felix Wiedmann (Autor), Yannick L'hoste (Autor), Walter E. Haefeli (Autor), Norbert Frey (Autor), Hugo A. Katus (Autor), Constanze Schmidt (Autor)
• Format: Książka
• Wydane: Frontiers Media S.A., 2021-03-01T00:00:00Z.
• Hasła przedmiotowe: article
• Dostęp online: Connect to this object online.

Atrial fibrillation (AF) is the most common sustained arrhythmia with a prevalence of up to 4% and an upwards trend due to demographic changes. It is associated with an increase in mortality and stroke incidences. While stroke risk can be significantly reduced through anticoagulant therapy, adequate...